Treating elderly patients with stage III NSCLC

Juan P. Wisnivesky; Gary M. Strauss

doi:10.1016/S1470-2045(12)70178-X

Treating elderly patients with stage III NSCLC

Juan P. Wisnivesky
, Gary M. Strauss

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English
Pages (from-to)	650-651
Number of pages	2
Journal	The Lancet Oncology
Volume	13
Issue number	7
DOIs	https://doi.org/10.1016/S1470-2045(12)70178-X
State	Published - Jul 2012
Externally published	Yes

Access to Document

10.1016/S1470-2045(12)70178-X

Cite this

@article{5279095e821d4df3926912aa4e36af3a,

title = "Treating elderly patients with stage III NSCLC",

author = "Wisnivesky, \{Juan P.\} and Strauss, \{Gary M.\}",

note = "Funding Information: JW is a member of the research board of EHE International and has received honorarium from Novartis Pharmaceutical, consulted for United Biosource, and received a research grant from GlaxoSmithKline. GS has no conflicts to declare.",

year = "2012",

month = jul,

doi = "10.1016/S1470-2045(12)70178-X",

language = "English",

volume = "13",

pages = "650--651",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd.",

number = "7",

}

TY - JOUR

T1 - Treating elderly patients with stage III NSCLC

AU - Wisnivesky, Juan P.

AU - Strauss, Gary M.

N1 - Funding Information: JW is a member of the research board of EHE International and has received honorarium from Novartis Pharmaceutical, consulted for United Biosource, and received a research grant from GlaxoSmithKline. GS has no conflicts to declare.

PY - 2012/7

Y1 - 2012/7

UR - https://www.scopus.com/pages/publications/84863108071

U2 - 10.1016/S1470-2045(12)70178-X

DO - 10.1016/S1470-2045(12)70178-X

M3 - Letter

C2 - 22622009

AN - SCOPUS:84863108071

SN - 1470-2045

VL - 13

SP - 650

EP - 651

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 7

ER -